$Infliximab as Therapeutic Option in Steroid-Refractory Ulcerative Colitis after Kidney Transplantation: Case Report$

Infliximab as Therapeutic Option in Steroid-Refractory Ulcerative Colitis after Kidney Transplantation: Case Report

Abstract In inflammatory bowel disease refractory to established therapies, treatment with biological agents such as monoclonal tumor necrosis factor-α antibodies is an established therapeutic option. However, application in renal allograft recipients is either not licensed or has not yet been syste...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2010-11, Vol.42 (9), p.3880-3882
Hauptverfasser:	Temme, J, Koziolek, M, Bramlage, C, Schaefer, I.M, Füzesi, L, Ramadori, G, Müller, G.A, Schwörer, H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - therapeutic use Biological and medical sciences Colitis, Ulcerative - complications Colitis, Ulcerative - diagnosis Colitis, Ulcerative - drug therapy Colonoscopy Drug Resistance Drug Therapy, Combination Female Fundamental and applied biological sciences. Psychology Fundamental immunology Gastroenterology. Liver. Pancreas. Abdomen Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Infliximab Kidney Diseases - complications Kidney Diseases - surgery Kidney Transplantation Male Medical sciences Middle Aged Other diseases. Semiology Steroids - therapeutic use Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Tissue, organ and graft immunology Transplantation, Homologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!